Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Therapeutics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00428168
What this trial is testing

Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment

Who this might be right for
Weight Gain
OBEcure Ltd. 36
Not applicableWithdrawnNCT05939765
What this trial is testing

Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study.

Who this might be right for
Schizophrenia
Psychiatric University Hospital, Zurich
Large-scale testing (Phase 3)Study completedNCT00300404
What this trial is testing

Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression

Who this might be right for
SchizophreniaMajor Depression
Zentrum für Integrative Psychiatrie 40
Post-approval studies (Phase 4)Study completedNCT00378092
What this trial is testing

A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode

Who this might be right for
Schizophrenia
Janssen Cilag N.V./S.A. 33
Testing effectiveness (Phase 2)Study completedNCT00356317
What this trial is testing

Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia

Who this might be right for
Schizophrenia
University of Miami 400
Large-scale testing (Phase 3)Study completedNCT00535574
What this trial is testing

Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia

Who this might be right for
Schizophrenia
Beersheva Mental Health Center 90
Not applicableStudy completedNCT02743143
What this trial is testing

Long-Term Exercise Training Therapy Versus Usual Care in Patients With Schizophrenia

Who this might be right for
Schizophrenia
St. Olavs Hospital 48
Large-scale testing (Phase 3)Study completedNCT04327843
What this trial is testing

Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY)

Who this might be right for
SchizophreniaMedication NonadherenceSchizo Affective Disorder
Case Western Reserve University 22
Testing effectiveness (Phase 2)Ended earlyNCT01939548
What this trial is testing

An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Pfizer 240
Not applicableEnded earlyNCT03917355
What this trial is testing

Nonverbal Synchrony, Therapeutic Alliance and Treatment Engagement in First Episode Schizophrenia

Who this might be right for
Schizophrenics
University Hospital, Montpellier 7
Post-approval studies (Phase 4)UnknownNCT00305474
What this trial is testing

Identification and Treatment of the Liability to Develop Schizophrenia

Who this might be right for
Schizophrenia
Central South University 100
Not applicableNot Yet RecruitingNCT07777315
What this trial is testing

Group Dialectical Behaviour Therapy (DBT) Skills Training for First Episode Psychosis

Who this might be right for
Psychosis
Centre for Addiction and Mental Health 32
Testing effectiveness (Phase 2)Looking for participantsNCT05240976
What this trial is testing

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia

Who this might be right for
Schizophrenia
China Medical University Hospital 80
Post-approval studies (Phase 4)Study completedNCT00757978
What this trial is testing

Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms

Who this might be right for
Schizophrenia
Hospital de Clinicas de Porto Alegre 22
Not applicableStudy completedNCT03554655
What this trial is testing

The Efficacy of Using a Smartphone App to Support Shared Decision Making in People With a Diagnosis of Schizophrenia

Who this might be right for
Schizophrenia, Schizotypal and Delusional Disorders
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital 194
Testing effectiveness (Phase 2)Study completedNCT03359785
What this trial is testing

Evaluate Multiple Oral Doses of Luvadaxistat in Adults With Schizophrenia

Who this might be right for
Schizophrenia
Neurocrine Biosciences 31
Not applicableStudy completedNCT06895421
What this trial is testing

Culturally Adapted Cognitive Behavior Therapy Based Guided Self-help Manual for Schizophrenia Spectrum Disorder

Who this might be right for
Receives Treatment As UsualReceives Culturally Adapted CBTp GSHSchizophrenia Disorders
University of the Punjab 170
Large-scale testing (Phase 3)Study completedNCT00236587
What this trial is testing

A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 100
Not applicableStudy completedNCT04418570
What this trial is testing

Hormonal and Inflammatory Biomarkers and Response to Cognitive Remediation in Recent-onset Psychosis

Who this might be right for
Psychotic Disorders
Corporacion Parc Tauli 28
Large-scale testing (Phase 3)Study completedNCT00518323
What this trial is testing

A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201
Next Page